Results 271 to 280 of about 159,989 (316)

Apolipoprotein(a): structure and biology

Frontiers in Bioscience, 2001
Apolipoprotein(a), apo(a), the distinctive glycoprotein constituent of lipoprotein(a), Lp(a), is synthesized in the liver, links covalently to apoB100-lipoprotein, and travels so linked in the plasma to tissue sites where removal mechanisms are yet undetermined.
A M, Scanu, K, Nakajima, C, Edelstein
openaire   +2 more sources

The apolipoprotein story

Atherosclerosis Supplements, 2006
The importance of different lipid and lipoprotein measurements, including LDL particle concentration and levels of apolipoproteins and triglycerides, in the prediction of future cardiac events continues to be debated. In summary, apo B is a strong, independent predictor of initial and recurrent coronary events, even during statin treatment, and recent ...
openaire   +2 more sources

Mutants of Apolipoproteins A and C

1986
The determination of the circulating levels of apolipoproteins has become common practice in clinical laboratories, in view of the apparent correlation between levels of specific apolipoproteins and increased or decreased cardiovascular risk [1, 2].
C. R. Sirtori, M. R. Lovati
openaire   +3 more sources

Apolipoprotein Mutants and Apolipoprotein Disorders

1983
A high degree of increased differentiation has come to the field of genetic dyslipoproteinemia. Most of the classical lipoprotein phenotypes have been shown to be genotypically heterogenous or subject to allelism. Characterization of the various apolipoproteins, of cellular lipoprotein receptors and of enzymes catalyzing intravascular changes in ...
openaire   +1 more source

Apolipoprotein Disorders

La Ricerca in Clinica e in Laboratorio, 1982
G, Assmann, H J, Menzel
openaire   +2 more sources

Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney function

Current Opinion in Lipidology, 2017
Purpose of review Chronic kidney disease (CKD) is a common disease with an estimated prevalence of 10–12%. There are pronounced differences between ethnicities with a 3-fold to 4-fold higher lifetime risk for end-stage kidney disease in African Americans compared to European Americans.
openaire   +2 more sources

The Apolipoproteins

1972
D S, Fredrickson, S E, Lux, P N, Herbert
openaire   +2 more sources

Analysis of Apolipoproteins

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1996
M F, Laker, K, Evans
openaire   +2 more sources

Apolipoprotein E

Molecular and Cellular Biochemistry, 1982
V I, Zannis, J L, Breslow
openaire   +2 more sources

Functional Domains of Apolipoprotein E and Apolipoprotein B

Acta Medica Scandinavica, 1987
T L, Innerarity, K H, Weisgraber, S C, Rall, R W, Mahley   +3 more
openaire   +2 more sources